Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Differential regulation of mesolimbic alpha 3/alpha 6 beta 2 and alpha 4 beta 2 nicotinic acetylcholine receptor sites and function after long-term oral nicotine to monkeys.

McCallum SE, Parameswaran N, Bordia T, Fan H, McIntosh JM, Quik M.

J Pharmacol Exp Ther. 2006 Jul;318(1):381-8. Epub 2006 Apr 18.

2.
3.

Genetic matters: thirty years of progress using mouse models in nicotinic research.

Marks MJ.

Biochem Pharmacol. 2013 Oct 15;86(8):1105-13. doi: 10.1016/j.bcp.2013.05.021. Epub 2013 Jun 6. Review.

4.

Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior.

Tuesta LM, Fowler CD, Kenny PJ.

Biochem Pharmacol. 2011 Oct 15;82(8):984-95. doi: 10.1016/j.bcp.2011.06.026. Epub 2011 Jun 29. Review.

5.

The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC, Marks MJ.

Biochem Pharmacol. 2007 Oct 15;74(8):1235-46. Epub 2007 Jul 27. Review.

6.

Nicotinic receptors as CNS targets for Parkinson's disease.

Quik M, Bordia T, O'Leary K.

Biochem Pharmacol. 2007 Oct 15;74(8):1224-34. Epub 2007 Jun 17. Review.

7.

[18F]Norchloro-fluoro-homoepibatidine .

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2008 Aug 12 [updated 2008 Aug 22].

8.

Nicotinic receptors in non-human primates: Analysis of genetic and functional conservation with humans.

Shorey-Kendrick LE, Ford MM, Allen DC, Kuryatov A, Lindstrom J, Wilhelm L, Grant KA, Spindel ER.

Neuropharmacology. 2015 Sep;96(Pt B):263-73. doi: 10.1016/j.neuropharm.2015.01.023. Epub 2015 Feb 7. Review.

9.

5-[123I]Iodo-3-[2(S)-2-azetidinylmethoxy]pyridine .

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 Jul 7 [updated 2006 Jul 24].

10.

[18F]5-(6-Fluorohexyn-1-yl)-3-[2(S)-2-azetidinylmethoxy]pyridine.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 Nov 12 [updated 2010 Jan 14].

11.

(-)-7-Methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 Apr 12 [updated 2009 Apr 3].

12.

Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation.

Mohamed TS, Jayakar SS, Hamouda AK.

Front Mol Neurosci. 2015 Nov 25;8:71. doi: 10.3389/fnmol.2015.00071. eCollection 2015. Review.

13.

6-[18F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 Jun 26 [updated 2008 Apr 11].

14.

α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Quik M, Wonnacott S.

Pharmacol Rev. 2011 Dec;63(4):938-66. doi: 10.1124/pr.110.003269. Review.

15.

2-[18F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 Jun 23 [updated 2008 Apr 8].

16.

Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine.

Ochoa EL, Li L, McNamee MG.

Mol Neurobiol. 1990 Fall-Winter;4(3-4):251-87. Review.

PMID:
2135395
17.

The nicotinic acetylcholine receptor: smoking and Alzheimer's disease revisited.

Mehta M, Adem A, Kahlon MS, Sabbagh MN.

Front Biosci (Elite Ed). 2012 Jan 1;4:169-80. Review.

18.

Cellular events in nicotine addiction.

Penton RE, Lester RA.

Semin Cell Dev Biol. 2009 Jun;20(4):418-31. doi: 10.1016/j.semcdb.2009.01.001. Epub 2009 Jan 20. Review.

19.

Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system.

Doyon WM, Thomas AM, Ostroumov A, Dong Y, Dani JA.

Biochem Pharmacol. 2013 Oct 15;86(8):1181-93. doi: 10.1016/j.bcp.2013.07.007. Epub 2013 Jul 19. Review.

Supplemental Content

Support Center